Pfizer to absorb Mylan, creating generic giant
NEW YORK (AP) - Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and...
NEW YORK (AP) - Pfizer is buying Mylan in an all-stock deal and combining the $10 billion generic pharmaceutical company with its own off-patent branded and...